Correlation of Urinary Albumin andβ-2-Microglobulin and Growth Hormone Excretion in Patients with Diabetes Mellitus and Short Stature*

1990 ◽  
Vol 71 (3) ◽  
pp. 611-617 ◽  
Author(s):  
FUPING PAN ◽  
JANET L. STEVENSON ◽  
DAVID L. DONALDSON ◽  
JANET LEVY ◽  
THOMAS WIEGMANN ◽  
...  
1959 ◽  
Vol XXXII (IV) ◽  
pp. 480-490 ◽  
Author(s):  
Olof Forsman ◽  
Carl A. Gemzell

ABSTRACT From the plasma of 30 out of 51 patients with various metabolic disorders a »growth-hormone-like« factor was concentrated which when injected into hypophysectomized rats increased the width of the tibial epiphysis. A similar factor had previously been concentrated from the plasma of acromegalic patients. It was tentatively concluded that this factor was identical with human growth hormone (HGH). Diabetes mellitus. Of 40 patients with diabetes mellitus 24 showed elevated plasma levels of human growth hormone (HGH). The frequency of elevated plasma levels was higher in young diabetics than in older diabetic patients; in many cases a nondiabetic complication was associated with an elevated level. In the plasma of 4 patients with diabetes mellitus and liver diseases an elevated plasma level of HGH was found while in 3 patients with Kimmelstiel-Wilson's syndrome no increase of HGH was found. Liver diseases. In the plasma of 4 patients with various liver diseases an elevated plasma level of HGH was found while in the plasma of another 4 patients no increase of HGH was found. Hypercholesterolaemia. In the plasma of 2 patients with familiar hypercholesterolaemia elevated levels of HGH was found while no HGH was found in a patient with an idiopathic type of the disease.


The Lancet ◽  
1972 ◽  
Vol 300 (7769) ◽  
pp. 155-160 ◽  
Author(s):  
P.H. Sönksen ◽  
M.C. Srivastava ◽  
ChristineV. Tompkins ◽  
J.D.N. Nabarro

1996 ◽  
Vol 43 (Suppl) ◽  
pp. S111-S113 ◽  
Author(s):  
YOH MIYASHITA ◽  
SYOICHIRO HASHIGUCHI ◽  
MITUYA TOTUKA ◽  
YOSHIAKI ITOH ◽  
JIN WATANABE ◽  
...  

2019 ◽  
Vol 10 (4) ◽  
pp. 8
Author(s):  
Keri Lillian DePatis ◽  
Catherine Harrington

Purpose: Chronic kidney disease (CKD) is a common complication among patients with diabetes mellitus; however, noncompliance with the recommended annual screening is common. Increased screening among high-risk patients is important to identify the early stages CKD, potentially resulting in earlier treatment, slower progression, fewer complications, and decreased healthcare expenditures. Motivational interviewing (MI) has previously been shown to be effective for various behaviors, such as smoking cessation and cholesterol level control. The objective of this study is to evaluate the effectiveness of pharmacist-delivered MI compared to typical education (TE) methods in increasing CKD screening and subsequent angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) initiation in high-risk patient populations. Methods: Pharmacists screened diabetic patients within their chronic disease management clinic to identify patients that are at high-risk for CKD, indicated by a score of 4 or greater on the validated SCORED screening tool. High-risk patients were randomized to one of four groups to receive either one or two face-to-face education sessions from a pharmacist or student pharmacist using either MI or TE methods. Patients were then given the option to have their urine tested with a dipstick to detect albumin and creatinine, provided at no cost. The primary outcome was to determine the rate of urinary albumin testing, and the secondary outcome was to determine the rate of ACE-I or ARB initiation in patients found to have albuminuria. Results: There were no significant differences in the rates of urinary albumin screening (87% in TE vs. 100% in MI, P = 0.4828) or subsequent ACE-I/ARB initiation (100% in TE and 50% in MI, P = 1.000) between education groups. Of the high-risk patients who underwent urinary albumin screening, 54% (n=15) were found to have proteinuria Conclusions: While it appears that MI does not impact patient acceptance rates of microalbuminuria screening and ACE-I/ARB initiation, this study demonstrates the feasibility of pharmacist-delivered microalbuminuria screening in patients at high-risk for CKD in the outpatient setting.   Article Type: Practice-Based Research


1982 ◽  
Vol 63 (5) ◽  
pp. 57-59
Author(s):  
E. A. Volkova ◽  
N. A. Stepanova

70 patients with diabetes mellitus treated with insulin were examined. When normoglycemia was reached, changes in the concentration of free and bound insulin in the blood were not observed, and the content of growth hormone, glucagon, and free fatty acids decreased.


Sign in / Sign up

Export Citation Format

Share Document